21 – 30 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Lower 68Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof-of-concept study
(
- Contribution to journal › Article
-
Mark
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Does early cognitive decline require the presence of both tau and amyloid-β?
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
A walk through tau therapeutic strategies
(
- Contribution to journal › Scientific review
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
(
- Contribution to journal › Scientific review
-
Mark
Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
(
- Contribution to journal › Article
-
Mark
Biomarkers for tau pathology
(
- Contribution to journal › Article
-
Mark
Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake
(
- Contribution to journal › Article